Atlas Trials

Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in Pediatrics

Clinical trial NCT03365648 · COMPLETED

Trial details

NCT number
NCT03365648
Sponsor
NTC srl
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Allergic Rhinoconjunctivitis
Start date
2017-09-15
Primary completion
2018-07-04
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.